BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kabashima A, Yao T, Sugimachi K, Tsuneyoshi M. Relationship between biologic behavior and phenotypic expression in intramucosal gastric carcinomas. Hum Pathol. 2002;33:80-86. [PMID: 11823976 DOI: 10.1053/hupa.2002.30182] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Hondo FY, Kishi H, Safatle-Ribeiro AV, Pessorrusso FCS, Ribeiro U, Maluf-Filho F. Characterization of the mucin phenotype can predict gastric cancer recurrence after endoscopic mucosal resection. Arq Gastroenterol. 2017;54:308-314. [PMID: 28954038 DOI: 10.1590/s0004-2803.201700000-38] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Lou G, Gao Y, Ning XM, Zhang QF. Expression and correlation of CD44v6, vascular endothelial growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-9 in Krukenberg tumor. World J Gastroenterol. 2005;11:5032-5036. [PMID: 16124061 DOI: 10.3748/wjg.v11.i32.5032] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
3 Atkinson JJ, Senior RM. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol 2003;28:12-24. [PMID: 12495928 DOI: 10.1165/rcmb.2002-0166TR] [Cited by in Crossref: 382] [Cited by in F6Publishing: 147] [Article Influence: 21.2] [Reference Citation Analysis]
4 Cavalcanti E, De Michele F, Lantone G, Panarese A, Caruso ML. Mucin phenotype of differentiated early gastric cancer: an immunohistochemistry study supporting therapeutic decision making. Cancer Manag Res 2019;11:5047-54. [PMID: 31354341 DOI: 10.2147/CMAR.S193994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Mori Y, Kono K, Matsumoto Y, Fujii H, Yamane T, Mitsumata M, Chen WT. The expression of a type II transmembrane serine protease (Seprase) in human gastric carcinoma. Oncology. 2004;67:411-419. [PMID: 15713998 DOI: 10.1159/000082926] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
6 Guo T, Yu Y, Yip GW, Baeg GH, Thike AA, Lim TK, Tan PH, Matsumoto K, Bay BH. Y-box binding protein 1 is correlated with lymph node metastasis in intestinal-type gastric cancer. Histopathology. 2015;66:491-499. [PMID: 25270600 DOI: 10.1111/his.12570] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
7 Sasaki S, Yashima K, Hayashi A, Takeda Y, Yasugi A, Koda M, Kawaguchi K, Harada K, Ito H, Murawaki Y. Clinicopathological and patient characteristics of early gastric neoplasia endoscopically resected with loss of Mlh1 expression. Oncol Lett 2011;2:217-22. [PMID: 22866067 DOI: 10.3892/ol.2010.231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Wakatsuki K, Yamada Y, Narikiyo M, Ueno M, Takayama T, Tamaki H, Miki K, Matsumoto S, Enomoto K, Yokotani T. Clinicopathological and prognostic significance of mucin phenotype in gastric cancer. J Surg Oncol. 2008;98:124-129. [PMID: 18521835 DOI: 10.1002/jso.21093] [Cited by in Crossref: 38] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
9 Namikawa T, Hanazaki K. Mucin phenotype of gastric cancer and clinicopathology of gastric-type differentiated adenocarcinoma. World J Gastroenterol. 2010;16:4634-4639. [PMID: 20872962 DOI: 10.3748/wjg.v16.i37.4634] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
10 Kubben FJ, Sier CF, van Duijn W, Griffioen G, Hanemaaijer R, van de Velde CJ, van Krieken JH, Lamers CB, Verspaget HW. Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer. Br J Cancer. 2006;94:1035-1040. [PMID: 16538217 DOI: 10.1038/sj.bjc.6603041] [Cited by in Crossref: 70] [Cited by in F6Publishing: 54] [Article Influence: 4.7] [Reference Citation Analysis]
11 Xing CG, Zhu BS, Fan XQ, Liu HH, Hou X, Zhao K, Qin ZH. Effects of LY294002 on the invasiveness of human gastric cancer in vivo in nude mice. World J Gastroenterol 2009;15:5044-52. [PMID: 19859997 DOI: 10.3748/wjg.15.5044] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
12 Song K, Yang Q, Yan Y, Yu X, Xu K, Xu J. Gastric mucin phenotype indicates aggressive biological behaviour in early differentiated gastric adenocarcinomas following endoscopic treatment. Diagn Pathol 2021;16:62. [PMID: 34256780 DOI: 10.1186/s13000-021-01122-2] [Reference Citation Analysis]
13 Hondo FY, Maluf-Filho F, Kishi HS, Uemura RS, Okawa L, Cecconello I, Sakai P. Predictive factors for local recurrence and incomplete resection of early gastric cancer treated by endoscopic resection: a Western experience. Can J Gastroenterol 2009;23:357-63. [PMID: 19440567 DOI: 10.1155/2009/986495] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
14 Fukaya M, Isohata N, Ohta H, Aoyagi K, Ochiya T, Saeki N, Yanagihara K, Nakanishi Y, Taniguchi H, Sakamoto H. Hedgehog signal activation in gastric pit cell and in diffuse-type gastric cancer. Gastroenterology. 2006;131:14-29. [PMID: 16831586 DOI: 10.1053/j.gastro.2006.05.008] [Cited by in Crossref: 99] [Cited by in F6Publishing: 90] [Article Influence: 6.6] [Reference Citation Analysis]
15 Shibata N, Watari J, Fujiya M, Tanno S, Saitoh Y, Kohgo Y. Cell kinetics and genetic instabilities in differentiated type early gastric cancers with different mucin phenotype. Hum Pathol. 2003;34:32-40. [PMID: 12605364 DOI: 10.1053/hupa.2003.2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
16 Namikawa T, Kobayashi M, Kitagawa H, Okabayashi T, Sugimoto T, Kuratani Y, Matsumoto M, Hanazaki K. Differentiated adenocarcinoma with a gastric phenotype in the stomach: difficulties in clinical and pathological diagnoses. Clin J Gastroenterol 2009;2:268-74. [PMID: 26192423 DOI: 10.1007/s12328-009-0090-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
17 Kushima R, Vieth M, Borchard F, Stolte M, Mukaisho K, Hattori T. Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach. Gastric Cancer 2006;9:177-84. [PMID: 16952035 DOI: 10.1007/s10120-006-0381-8] [Cited by in Crossref: 62] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
18 Takano K, Hasegawa G, Jiang S, Kurosaki I, Hatakeyama K, Iwanari H, Tanaka T, Hamakubo T, Kodama T, Naito M. Immunohistochemical staining for P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha may complement mucin phenotype of differentiated-type early gastric carcinoma. Pathol Int 2009;59:462-70. [PMID: 19563409 DOI: 10.1111/j.1440-1827.2009.02394.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
19 Canzonieri V, Colarossi C, Del Col L, Perin T, Talamini R, Sigon R, Cannizzaro R, Aiello E, Buonadonna A, Italia F, Massi D, Carbone A, Memeo L. Exocrine and Endocrine Modulation in Common Gastric Carcinoma. Am J Clin Pathol 2012;137:712-21. [DOI: 10.1309/ajcpm13kvnczqbuv] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
20 Shibagaki K, Fukuyama C, Mikami H, Izumi D, Yamashita N, Mishiro T, Oshima N, Ishimura N, Sato S, Ishihara S, Nagase M, Araki A, Ishikawa N, Maruyama R, Kushima R, Kinoshita Y. Gastric foveolar-type adenomas endoscopically showing a raspberry-like appearance in the Helicobacter pylori -uninfected stomach. Endosc Int Open. 2019;7:E784-E791. [PMID: 31198840 DOI: 10.1055/a-0854-3818] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
21 Schupp DJ, Huck BP, Sykora J, Flechtenmacher C, Gorenflo M, Koch A, Sack F, Haass M, Katus HA, Ulmer HE, Hagl S, Otto HF, Schnabel PA. Right ventricular expression of extracellular matrix proteins, matrix-metalloproteinases, and their inhibitors over a period of 3 years after heart transplantation. Virchows Arch 2006;448:184-94. [DOI: 10.1007/s00428-005-0050-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
22 Kumarasinghe MP, Lim TK, Ooi CJ, Luman W, Tan SY, Koh M. Tubule neck dysplasia: precursor lesion of signet ring cell carcinoma and the immunohistochemical profile. Pathology. 2006;38:468-471. [PMID: 17008295 DOI: 10.1080/00313020600924542] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
23 Kwee RM, Kwee TC. Predicting lymph node status in early gastric cancer. Gastric Cancer. 2008;11:134-148. [PMID: 18825308 DOI: 10.1007/s10120-008-0476-5] [Cited by in Crossref: 98] [Cited by in F6Publishing: 90] [Article Influence: 7.5] [Reference Citation Analysis]
24 Li ZM, Pu YW, Zhu BS. Blockade of NF-κB nuclear translocation results in the inhibition of the invasiveness of human gastric cancer cells. Oncol Lett 2013;6:432-6. [PMID: 24137341 DOI: 10.3892/ol.2013.1390] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
25 Kawaguchi K, Yashima K, Koda M, Tsutsumi A, Kitaoka S, Andachi H, Hosoda A, Kishimoto Y, Shiota G, Ito H, Murawaki Y. Fhit expression in human gastric adenomas and intramucosal carcinomas: correlation with Mlh1 expression and gastric phenotype. Br J Cancer 2004;90:672-7. [PMID: 14760383 DOI: 10.1038/sj.bjc.6601601] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
26 Zhao Z, Sun Y, Hou N, Teng Y, Wang Y, Yang X. Capn8 promoter directs the expression of Cre recombinase in gastric pit cells of transgenic mice. Genesis 2009;47:674-9. [PMID: 19603510 DOI: 10.1002/dvg.20552] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
27 Tajima Y, Yamazaki K, Nishino N, Morohara K, Yamazaki T, Kaetsu T, Suzuki S, Kawamura M, Kumagai K, Kusano M. Gastric and intestinal phenotypic marker expression in gastric carcinomas and recurrence pattern after surgery-immunohistochemical analysis of 213 lesions. Br J Cancer 2004;91:1342-8. [PMID: 15354218 DOI: 10.1038/sj.bjc.6602147] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
28 Namikawa T, Kitagawa H, Iwabu J, Okabayashi T, Sugimoto T, Kobayashi M, Hanazaki K. Clinicopathological Properties of the Superficial Spreading Type Early Gastric Cancer. J Gastrointest Surg 2010;14:52-7. [DOI: 10.1007/s11605-009-1059-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
29 Yao T, Utsunomiya T, Oya M, Nishiyama K, Tsuneyoshi M. Extremely well-differentiated adenocarcinoma of the stomach: clinicopathological and immunohistochemical features. World J Gastroenterol. 2006;12:2510-2516. [PMID: 16688795 DOI: 10.3748/wjg.v12.i16.2510] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
30 Morohara K, Tajima Y, Nakao K, Nishino N, Aoki S, Kato M, Sakamoto M, Yamazaki K, Kaetsu T, Suzuki S, Tsunoda A, Tachikawa T, Kusano M. Gastric and intestinal phenotypic cell marker expressions in gastric differentiated-type carcinomas: association with E-cadherin expression and chromosomal changes. J Cancer Res Clin Oncol 2006;132:363-75. [PMID: 16447040 DOI: 10.1007/s00432-005-0062-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
31 Yamamoto K, Kato M, Takahashi M, Haneda M, Shinada K, Nishida U, Yoshida T, Sonoda N, Ono S, Nakagawa M. Clinicopathological analysis of early-stage gastric cancers detected after successful eradication of Helicobacter pylori. Helicobacter. 2011;16:210-216. [PMID: 21585606 DOI: 10.1111/j.1523-5378.2011.00833.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
32 Nakamura T, Yao T, Kabashima A, Nishiyama K, Maehara Y, Tsuneyoshi M. Loss of phenotypic expression is related to tumour progression in early gastric differentiated adenocarcinoma. Histopathology 2005;47:357-67. [PMID: 16178890 DOI: 10.1111/j.1365-2559.2005.02242.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
33 Yamazaki K, Tajima Y, Makino R, Nishino N, Aoki S, Kato M, Sakamoto M, Morohara K, Kaetsu T, Kusano M. Tumor differentiation phenotype in gastric differentiated-type tumors and its relation to tumor invasion and genetic alterations. World J Gastroenterol 2006;12:3803-9. [PMID: 16804962 DOI: 10.3748/wjg.v12.i24.3803] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]